Literature DB >> 25385789

Meta-Analysis of Anti-Toxoplasma gondii IgM Antibodies in Acute Psychosis.

Joel M Monroe1, Peter F Buckley2, Brian J Miller3.   

Abstract

INTRODUCTION: A number of different infections are associated with acute psychosis. However, relationships between infections and acute psychosis in patients with schizophrenia have not been extensively explored. Exposure to Toxoplasma gondii is a replicated risk factor for schizophrenia. Previous studies have focused on T. gondii IgG antibodies, which are a marker of lifetime exposure, whereas IgM antibodies are a marker of acute/recent exposure, persistent infection, or reinfection. We performed a meta-analysis of T. gondii IgM antibodies and acute psychosis, to further investigate whether infections may be associated with relapse in schizophrenia.
METHODS: We identified articles by systematic searches of PubMed, PsycINFO, and ISI databases. We included studies, in English, of serum T. gondii IgM antibodies in patients with acute psychosis and controls.
RESULTS: Sixteen independent samples (2353 patients and 1707 controls) met inclusion criteria. Data were pooled using a random effects model. There was a significant increase in risk of positive T. gondii IgM antibodies in acute psychosis compared with controls (7.6% vs 5.7%, OR = 1.68, 95% CI = 1.23-2.27, P = .001). The association was stronger for patients with chronic schizophrenia (8.7% vs 4.6%, OR = 2.54, 95% CI = 1.63-3.96, P < .001) than first-episode psychosis. In meta-regression analyses, age, sex, and publication year were unrelated to the association; however, there was a significant association with geographic region. DISCUSSION: An increased seroprevalence of T. gondii IgM in patients with acute psychosis complements and extends previous findings, suggesting that infections may be relevant to the etiopathophysiology of relapse in some patients with schizophrenia.
© The Author 2014. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  infection; meta-analysis; psychosis; relapse; toxoplasmosis

Mesh:

Substances:

Year:  2014        PMID: 25385789      PMCID: PMC4466176          DOI: 10.1093/schbul/sbu159

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  58 in total

1.  Methods for exploring heterogeneity in meta-analysis.

Authors:  F Song; T A Sheldon; A J Sutton; K R Abrams; D R Jones
Journal:  Eval Health Prof       Date:  2001-06       Impact factor: 2.651

2.  Antibodies to infectious agents in individuals with recent onset schizophrenia.

Authors:  F Markus Leweke; Christoph W Gerth; Dagmar Koethe; Joachim Klosterkötter; Inna Ruslanova; Bogdana Krivogorsky; E Fuller Torrey; Robert H Yolken
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-02       Impact factor: 5.270

3.  The comparison of percentages in matched samples.

Authors:  W G COCHRAN
Journal:  Biometrika       Date:  1950-12       Impact factor: 2.445

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Toxoplasma gondii: Serological recognition of reinfection.

Authors:  Katarzyna Dzitko; Pawel Staczek; Justyna Gatkowska; Henryka Dlugonska
Journal:  Exp Parasitol       Date:  2005-11-14       Impact factor: 2.011

6.  A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence.

Authors:  Dunja Hinze-Selch; Walter Däubener; Lena Eggert; Sükran Erdag; Renate Stoltenberg; Sibylle Wilms
Journal:  Schizophr Bull       Date:  2007-03-26       Impact factor: 9.306

7.  Antibodies to Toxoplasma gondii in individuals with mania.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Crystal Vaughan; Emily Katsafanas; Sunil Khushalani; Robert Yolken
Journal:  Bipolar Disord       Date:  2013-09-18       Impact factor: 6.744

8.  Differences in onset of disease and severity of psychopathology between toxoplasmosis-related and toxoplasmosis-unrelated schizophrenia.

Authors:  D Holub; J Flegr; E Dragomirecká; M Rodriguez; M Preiss; T Novák; J Čermák; J Horáček; P Kodym; J Libiger; C Höschl; L B Motlová
Journal:  Acta Psychiatr Scand       Date:  2012-11-05       Impact factor: 6.392

9.  Specific anti-Toxoplasma antibodies in relation to infection and reinfection using different infective stages.

Authors:  M Hassan; M Hegab; B E Abaza; M E Nasr; N M Mowafy
Journal:  J Egypt Soc Parasitol       Date:  1999

10.  A 4-year evaluation of toxoplasmosis seroprevalence in the general population and in women of reproductive age in central Italy.

Authors:  M Mosti; B Pinto; A Giromella; S Fabiani; R Cristofani; M Panichi; F Bruschi
Journal:  Epidemiol Infect       Date:  2012-12-11       Impact factor: 4.434

View more
  25 in total

Review 1.  Inflammation in Mental Disorders: Is the Microbiota the Missing Link?

Authors:  Sophie Ouabbou; Ying He; Keith Butler; Ming Tsuang
Journal:  Neurosci Bull       Date:  2020-06-27       Impact factor: 5.203

Review 2.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 3.  Toxoplasma gondii and schizophrenia: a review of published RCTs.

Authors:  Sam D Chorlton
Journal:  Parasitol Res       Date:  2017-05-15       Impact factor: 2.289

4.  Infection and characterization of Toxoplasma gondii in human induced neurons from patients with brain disorders and healthy controls.

Authors:  Eleonora Passeri; Lorraine Jones-Brando; Claudia Bordón; Srona Sengupta; Ashley M Wilson; Amedeo Primerano; Judith L Rapoport; Koko Ishizuka; Shin-ichi Kano; Robert H Yolken; Akira Sawa
Journal:  Microbes Infect       Date:  2015-10-09       Impact factor: 2.700

5.  Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

Review 6.  Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Authors:  Elyse J Singer; April D Thames
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

Review 7.  Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Neuropsychopharmacology       Date:  2016-09-22       Impact factor: 7.853

Review 8.  Schizophrenia and Infections: The Eyes Have It.

Authors:  E Fuller Torrey; Robert H Yolken
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

9.  Electrophysiological Neuroimaging using sLORETA Comparing 100 Schizophrenia Patients to 48 Patients with Major Depression.

Authors:  Andy R Eugene; Jolanta Masiak
Journal:  Brain (Bacau)       Date:  2014-12

Review 10.  The Historical Development of Immunoendocrine Concepts of Psychiatric Disorders and Their Therapy.

Authors:  Holger Steinberg; Kenneth C Kirkby; Hubertus Himmerich
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.